References
Arunachalam G, Yao H, Sundar IK, Caito S, Rahman I (2010). SIRT1
regulates oxidant- and cigarette smoke-induced eNOS acetylation in
endothelial cells: Role of resveratrol. Biochem Biophys Res Commun
393: 66-72.
Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R (2016). COPD and
stroke: are systemic inflammation and oxidative stress the missing
links? Clin Sci (London, England : 1979) 130: 1039-1050.
Azad GK, Tomar RS (2014). Ebselen, a promising antioxidant drug:
mechanisms of action and targets of biological pathways. Mol Biol Rep
41: 4865-4879.
Barnes PJ, Celli BR (2009). Systemic manifestations and comorbidities of
COPD. Eur Respir J 33: 1165-1185.
Bartalis J, Chan WG, Wooten JBJAc (2007). A new look at radicals in
cigarette smoke. Anal Chem 79: 5103-5106.
Bernardo I, Bozinovski S, Vlahos R (2015). Targeting oxidant-dependent
mechanisms for the treatment of COPD and its comorbidities. Pharmacol
Ther 155: 60-79.
Brassington K, Selemidis S, Bozinovski S, Vlahos R (2019). New frontiers
in the treatment of comorbid cardiovascular disease in chronic
obstructive pulmonary disease. Clin Sci (London, England: 1979)
133: 885-904.
Chan CK, Vanhoutte PMJAPSB (2013). Hypoxia, vascular smooth muscles and
endothelium. Acta Pharm Sin B 3: 1-7.
Chan SM, Cerni C, Passey S, Seow HJ, Bernardo I, van der Poel C,
et al. (2020). Cigarette smoking exacerbates skeletal muscle injury
without compromising its regenerative capacity. Am J Respir Cell Mol
Biol 62(2):217-230.
Chew P, Yuen DYC, Stefanovic N, Pete J, Coughlan MT, Jandeleit-Dahm
KA, et al. (2010). Antiatherosclerotic and renoprotective effects
of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.
Diabetes 59: 3198-3207.
Crack PJ, Taylor JM, Flentjar NJ, De Haan J, Hertzog P, Iannello
RC, et al. (2001). Increased infarct size and exacerbated
apoptosis in the glutathione peroxidase‐1 (Gpx‐1) knockout mouse brain
in response to ischemia/reperfusion injury. J Neurochem 78:1389-1399.
de Haan JB, Cooper ME (2011). Targeted antioxidant therapies in
hyperglycemia-mediated endothelial dysfunction. Front Biosci (Scholar
edition) 3: 709-729.
Duong C, Seow HJ, Bozinovski S, Crack PJ, Anderson GP, Vlahos R (2010).
Glutathione peroxidase-1 protects against cigarette smoke-induced lung
inflammation in mice. Am J Physiol Lung Cell Mol Physiol 299:L425-433.
Edirisinghe I, Rahman I (2010). Cigarette smoke–mediated oxidative
stress, shear stress, and endothelial dysfunction: role of VEGFR2. Ann N
Y Acad Sci 1203: 66-72.
Endemann DH, Schiffrin EL (2004). Endothelial dysfunction. J Am Soc
Nephrol 15: 1983-1992.
Geraghty P, Hardigan AA, Wallace AM, Mirochnitchenko O, Thankachen J,
Arellanos L, et al. (2013). The glutathione peroxidase 1-protein
tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant
of airway inflammation and alveolar destruction. Am J Respir Cell Mol
Biol 49: 721-730.
Hansen MJ, Chen H, Jones JE, Langenbach SY, Vlahos R, Gualano RC,
et al. (2013). The lung inflammation and skeletal muscle wasting
induced by subchronic cigarette smoke exposure are not altered by a
high-fat diet in mice. PLoS One 8: e80471.
James AL, Wenzel S (2007). Clinical relevance of airway remodelling in
airway diseases. Eur Respir J 30: 134-155.
Kluchova Z, Petrasova D, Joppa P, Dorkova Z, Tkacova R (2007). The
association between oxidative stress and obstructive lung impairment in
patients with COPD. Physiol Res 56: 51-56.
Kolluru GK, Bir SC, Kevil CG (2012). Endothelial dysfunction and
diabetes: effects on angiogenesis, vascular remodeling, and wound
healing. Int J Vasc Med 2012: 918267.
Li H, Forstermann U (2014). Pharmacological prevention of eNOS
uncoupling. Curr Pharm Des 20: 3595-3606.
Mukhopadhyay S, Hoidal JR, Mukherjee TK (2006). Role of TNFalpha in
pulmonary pathophysiology. Resp Res 7: 125.
Oostwoud LC, Gunasinghe P, Seow HJ, Ye JM, Selemidis S, Bozinovski
S, et al. (2016). Apocynin and ebselen reduce influenza A
virus-induced lung inflammation in cigarette smoke-exposed mice. Sci Rep
6: 20983.
Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, et
al. (1998). Inflammatory cells and mediators in bronchial lavage of
patients with chronic obstructive pulmonary disease. Eur Respir J
12: 380-386.
Rask-Madsen C, King GL (2007). Mechanisms of Disease: endothelial
dysfunction in insulin resistance and diabetes. Nat Clin Pract
Endocrinol Metab 3: 46-56.
Rincon M, Irvin CG (2012). Role of IL-6 in asthma and other inflammatory
pulmonary diseases. Int J Biol Sci 8: 1281-1290.
Santos M, Oliveira A, Viegas-Crespo A, Vicente L, Barreiros A, Monteiro
P, et al. (2004). Systemic markers of the redox balance in
chronic obstructive pulmonary disease. Biomarkers 9: 461-469.
Sarker KP, Biswas KK, Rosales JL, Yamaji K, Hashiguchi T, Lee KY,
et al. (2003). Ebselen inhibits NO-induced apoptosis of differentiated
PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and
activation of p44/42 MAPK and Bcl-2. J Neurochem 87: 1345-1353.
Sarma BK, Mugesh G (2008). Antioxidant activity of the anti-inflammatory
compound ebselen: a reversible cyclization pathway via selenenic and
seleninic acid intermediates. Chemistry 14: 10603-10614.
Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, et
al. (2011). Altered mitochondrial dynamics contributes to endothelial
dysfunction in diabetes mellitus. Circulation 124: 444-453.
Sin DD, Anthonisen NR, Soriano JB, & Agusti AG (2006). Mortality in
COPD: Role of comorbidities.Eur Respir J 28: 1245-1257.
Sin DD, Man SF (2005). Chronic obstructive pulmonary disease as a risk
factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc
2: 8-11.
Smith SM, Min J, Ganesh T, Diebold B, Kawahara T, Zhu Y, et al.(2012). Ebselen and congeners inhibit NADPH oxidase 2-dependent
superoxide generation by interrupting the binding of regulatory
subunits. Chem Biol 19: 752-763.
Tabit CE, Chung WB, Hamburg NM, Vita JA (2010). Endothelial dysfunction
in diabetes mellitus: molecular mechanisms and clinical implications.
Rev Endocr Metab Disord 11: 61-74.
Takasago T, Peters EE, Graham DI, Masayasu H, Macrae IM (1997).
Neuroprotective efficacy of ebselen, an anti-oxidant with
anti-inflammatory actions, in a rodent model of permanent middle
cerebral artery occlusion. Br J Pharmacol 122: 1251-1256.
Tkacova R, Kluchova Z, Joppa P, Petrasova D, & Molcanyiova A (2007).
Systemic inflammation and systemic oxidative stress in patients with
acute exacerbations of COPD. Respir Med 101: 1670-1676.
The Lung Foundation. COPD: The Statistics. Available from
http://lungfoundation.com.au/health-professionals/clinical-resources/copd/copd-the-statistics/.
[Accessed: 15.3.2017].
To EE, Vlahos R, Luong R, Halls ML, Reading PC, King PT, et al.(2017). Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a
target for antiviral therapy. Nat Commun 8: 69.
Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009). Endothelial
dysfunction as a target for prevention of cardiovascular disease.
Diabetes Care 32 Suppl 2: S314-321.
Vlahos R, Bozinovski S (2014). Recent advances in pre-clinical mouse
models of COPD. Clin Sci (London, England : 1979) 126: 253-265.
Vlahos R, Bozinovski S, Chan SPJ, Ivanov S, Lindén A, Hamilton JA,
et al. (2010). Neutralizing granulocyte/macrophage colony–stimulating
factor inhibits cigarette smoke–induced lung inflammation. Am J Respir
Crit Care Med 182: 34-40.
Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, et
al. (2006). Differential protease, innate immunity, and NF-kappaB
induction profiles during lung inflammation induced by subchronic
cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol
290: L931-945.
Vlahos R, Selemidis S (2014). NADPH oxidases as novel pharmacologic
targets against influenza A virus infection. Mol pharmacol 86:747-759.
Vlahos R, Stambas J, Bozinovski S, Broughton BRS, Drummond GR, Selemidis
S (2011). Inhibition of Nox2 Oxidase Activity Ameliorates Influenza A
Virus-Induced Lung Inflammation. PLoS Pathog 7: e1001271.
The World Health Organisation. The top 10 causes of death.Available from
http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death..
Yatmaz S, Seow H, Gualano R, Wong Z, Stambas J, Selemidis S, et
al. (2013). Glutathione Peroxidase-1 Reduces Influenza A Virus–Induced
Lung Inflammation. Am J Respir Cell Mol Biol 48: 17-26.
Zhang M, Nomura A, Uchida Y, Iijima H, Sakamoto T, Iishii Y, et
al. (2002). Ebselen suppresses late airway responses and airway
inflammation in guinea pigs. Free radic biol Med 32: 454-464.
Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM (2006). Adverse effects of
cigarette smoke on NO bioavailability: role of arginine metabolism and
oxidative stress. Hypertension 48: 278-285.